Get the Daily Brief
Latest Biotech News
Funding boost for oral peptide platform targeting clinic-ready convenience
Pinnacle Medicines added $89 million to advance oral peptide drug candidates designed to combine biologic-like properties with small-molecule-style dosing. The startup says its lead program,...
Japan shows multi-decade rise in therapy-related acute myeloid leukemia
Population-based epidemiology in Japan reports an increase in therapy-related acute myeloid leukemia (tAML) over three decades, tying the trend to prior chemotherapy and radiation exposure. The...
Whole-body MRI moves into outcome prediction for advanced ovarian cancer
Researchers published data in the British Journal of Cancer suggesting whole-body diffusion-weighted MRI (WB-DWI/MRI) can predict treatment outcomes in advanced ovarian cancer after neoadjuvant...
Durvalumab plus tremelimumab tested in phase 2 for advanced thyroid cancer
The phase II GETNE-DUTHY trial reports on durvalumab plus tremelimumab in advanced thyroid carcinoma. The study evaluates the checkpoint inhibitor combination approach led by Capdevila and...
New target for colorectal immunotherapy: glycocholic acid blockade
A study describes circulating glycocholic acid (GCA) as a modulator of colorectal cancer response to immune checkpoint therapy, and reports that blocking GCA enhances immunotherapy efficacy. The...
V-ATPase highlighted in blastocyst cavitation using single-molecule embryo modeling
A research team introduced a single-small-molecule-based human embryo model to investigate blastocyst cavitation and identified V-ATPase as a key player in the process. The findings were published...
AI systems face clinical reality check on heart monitoring limitations
A commentary argues that algorithms flag arrhythmias but struggle with broader human context, using irregular heartbeat detection as an entry point. The piece emphasizes that recognizing...
NIH funding generates large economic returns while raising expectations for accountability
A research advocacy group, United for Medical Research, reports that NIH grant money stimulated the US economy with a measured economic return. The report also argues that certain NIH funding...
FDA delay that derailed Kezar’s autoimmune hepatitis trial and sale process
Kezar Life Sciences was forced to shut down after the FDA’s four-month delay in a key trial-design meeting arrived too late for its autoimmune hepatitis program. The company said it had reached an...
Oral GLP-1 approval sparks immediate market debate for Eli Lilly’s Foundayo
Eli Lilly’s oral GLP-1 obesity drug Foundayo (orforglipron) won FDA approval, but the initial stock reaction faded as analysts debated how fast prescriptions can build. The report said Lilly...
Pinnacle Medicines raises $89M to advance oral peptide programs modeled after injectable biologics
Pinnacle Medicines added $89 million to fund peptide drugs designed to combine biologic-like efficacy with oral small-molecule dosing convenience. The startup’s lead program—built within...
Real-world safety evidence expands for second-line diabetes drugs in elderly patients
New real-world evidence published in Nature Communications is adding to safety comparisons for second-line antihyperglycemic agents in older adults with type 2 diabetes. The study, led by Kim, Bu,...
Whole-body diffusion MRI predicts outcomes after neoadjuvant chemotherapy in advanced ovarian cancer
A study in the British Journal of Cancer reports that whole-body diffusion-weighted MRI (WB-DWI/MRI) can predict treatment outcomes in advanced ovarian cancer following neoadjuvant chemotherapy....
Distributed computing framework targets breast cancer recurrence prediction using multi-institution data
Researchers unveiled a distributed fusion framework designed to predict breast cancer recurrence using MapReduce-style processing for large datasets. The work, described as a distributed fusion...
Glycocholic acid identified as a lever on colorectal immunotherapy efficacy
A study highlighted circulating glycocholic acid (GCA) as a key modulator of immune checkpoint therapy efficacy in colorectal cancer. The report describes new mechanistic findings linking...
Healthcare AI deployment blueprint centers on workflow fit and proprietary data
A new perspective piece from Flare Capital Partners argues that healthcare AI winners will be determined less by model novelty and more by deployment readiness—especially integration into clinical...
Epidemiology study flags rising therapy-related acute myeloid leukemia incidence in Japan
A population-based epidemiological investigation in Japan reports an escalation in therapy-related acute myeloid leukemia (tAML) incidence over three decades. The study focuses on secondary blood...
Startup-agnostic safety and trial operations insight: reloadable cards emerge as a study-participant incentive tool
A practical trial-operations report argues that reloadable payment cards can outperform cash or one-time checks for compensating clinical trial participants. The piece focuses on tracking,...
Oral GLP-1 approval stokes near-term competition questions
Eli Lilly won FDA approval for its oral obesity drug Foundayo (orforglipron), but a quick post-approval stock bounce faded as investors focused on execution and pricing against Novo Nordisk’s oral...
Financing for oral peptides aims to mimic injectable performance
Pinnacle Medicines raised $89 million to advance oral peptide therapeutics engineered to deliver injectable-biologic-like properties. The startup says its lead program, incubated with OrbiMed, is...